INTEGRATED BIOPHARMA INC Deferred Income Tax Assets, Net
INTEGRATED BIOPHARMA INC (INBP) had Deferred Income Tax Assets, Net of $3.59 million as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-05-08
- 2026-03-31: Deferred Income Tax Assets, Net $3.59M.
- 2025-12-31: Deferred Income Tax Assets, Net $3.39M.
- 2025-09-30: Deferred Income Tax Assets, Net $3.27M.
- 2025-06-30: Deferred Income Tax Assets, Net $3.34M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-03-31 | $3.59M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.39M 10-Q · filed 2026-02-11 |
| 2025-09-30 | $3.27M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.34M 10-Q · filed 2026-05-08 |
| 2025-03-31 | $4.11M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.35M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $4.40M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $4.60M 10-K · filed 2025-09-23 |
| 2024-03-31 | $4.71M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $4.79M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $4.72M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.73M 10-K · filed 2024-09-20 |
| 2023-03-31 | $4.76M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.76M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $4.76M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.80M 10-K · filed 2023-09-15 |
| 2022-03-31 | $3.67M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.75M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $3.31M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $3.27M 10-K · filed 2022-09-13 |
| 2021-03-31 | $1.46M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.86M 10-Q · filed 2021-02-12 |
| 2020-09-30 | $1.61M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.88M 10-K · filed 2021-09-02 |
| 2020-03-31 | $596.00K 10-Q · filed 2020-05-13 |
| 2019-06-30 | $534.00K 10-K · filed 2020-09-23 |